Evidence map›Paper›PMID 23296190›Full record

ArticleJournal of innate immunity2013

Antiviral innate immunity disturbs podocyte cell function.

Michifumi Yamashita, Carrie A Millward, Hiroyuki Inoshita, Paramananda Saikia, Saurabh Chattopadhyay, Ganes C Sen, Steven N Emancipator

Open access · bronzeAbstract read
In one paragraph

Article in Journal of innate immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. The Life of a Kidney Podocyte.Acta physiologica (Oxford, England) · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Damage-Associated Molecular Patterns and Pattern Recognition Receptors in the Podocyte.Journal of the American Society of Nephrology : JASN · 2025
    Review
  6. Review
  7. Type I IFN in Glomerular Disease: Scarring beyond the STING.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. A New Vision of IgA Nephropathy: The Missing Link.International journal of molecular sciences · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Michifumi YamashitaDepartment of Pathology, University Hospitals Case Medical Center, Cleveland Clinic, Cleveland, OH 44106, USA. mxy53@cwru.edu
Carrie A Millward
Hiroyuki Inoshita
Paramananda Saikia
Saurabh Chattopadhyay
Ganes C Sen
Steven N Emancipator
Case Western Reserve University · USCleveland Clinic Lerner College of Medicine · USUniversity Hospitals Case Medical Center · US

Funding

Cellular Determinants of Apoptosis in Virus-Infected CellsR01AI073303 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI SEN, GANES C. · 2008 to 2018
$3.5M
T Cells Control IgA Glycosylation, Evoke IgA NephropathyR01DK059334 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI EMANCIPATOR, STEVEN N · 2002 to 2005
$1.1M
Cellular determinants of apoptosis in virus-infected cellsR56AI073303 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI SEN, GANES C. · 2013 to 2013
$372k
Role of innate responses to viruses in the genesis of IgA NephropathyI01BX000376 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI EMANCIPATOR, STEVEN N · 2009 to 2012
–
BLRD VA I01 BX000376NIAID NIH HHS AI073303NIAID NIH HHS R01 AI073303NIAID NIH HHS R56 AI073303NIDDK NIH HHS R01 DK059334
6 · The paper itself

Abstract

Immunoglobulin A nephropathy (IgAN) is the most common form of glomerulonephritis throughout the world. A majority (approx. 60%) of patients with IgAN experience disease exacerbations associated with an acute respiratory or gastrointestinal illness that appears to represent a viral infection. However, the exact mechanism of the disease exacerbation by viral infection is not understood, especially at the cellular and molecular levels. Here we report that glomerular podocytes express the major sensors for double-stranded RNA (dsRNA), a common byproduct of viral replication. In addition to these receptors, Toll-like receptor 3 (TLR3) and retinoic acid-inducible gene 1 (RIG-I)-like helicases (RLHs), podocytes express the collateral proteins required to support intracellular signaling. The pathways that mediate responses to dsRNA are fully functional in podocytes. The transcription factor interferon regulatory factor 3 (IRF3) and nuclear factor kappa B (NF-ĸB) are phosphorylated and translocate to the nucleus, and dsRNA increases synthesis of proteins driven by IRF3 (P54, P56 and P60) or NF-ĸB (interleukin 8 and A20). Furthermore, dsRNA suppresses podocyte cell migration, alters the expression of a panel of podocyte essential proteins (nephrin, podocin and CD2-associated protein or CD2AP) and changes transepithelial albumin flux. These effects are dsRNA sensor-specific: TLR3-/- podocytes do not respond to extracellular dsRNA, while intracellular dsRNA has no effect on podocytes bearing a dominant negative form of the major active RLH. These results demonstrate that innate responses to viruses can disturb podocyte cell function in vitro.

Indexed as

Immunity, InnateActive Transport, Cell NucleusAnimalsCell MovementCell NucleusCells, CulturedGlomerulonephritis, IGAInterferon Regulatory Factor-3Membrane ProteinsMiceMice, KnockoutNerve Tissue ProteinsNF-kappa BPodocytesReceptors, Cell SurfaceRNA, Double-StrandedInterferon Regulatory Factor-3Irf3 protein, mouseMembrane ProteinsNerve Tissue ProteinsNF-kappa BReceptors, Cell SurfaceRNA, Double-StrandedRobo3 protein, mouseRoundabout ProteinsTLR3 protein, mouseToll-Like Receptor 3

Identifiers

PMID23296190
PMCPMC3724426
OpenAlexW2023251562

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.